KPC-PRODUCING Serratia marcescens IN A HOME-CARE PATIENT FROM RECIFE, BRAZIL
| Data(s) |
01/08/2015
|
|---|---|
| Resumo |
SUMMARY In this brief communication we describe the occurrence of a KPC-producing Serratia marcescensisolate in a home-care patient from Recife, Brazil. The blaKPC, blaSPM, blaIMP, blaVIMblaOXA, blaCTX-M, blaSHV, blaTEM and blaGES genes were investigated by Polymerase Chain Reaction (PCR) and DNA sequencing. The isolate was positive for blaKPC-2 and blaTEM-1 and was resistant to aztreonam, cefepime, cefotaxime, imipenem, meropenem, gentamicin, ciprofloxacin and cefazidime, and susceptible only to amikacin, tigecycline and gatifloxacin. This is the first report in Brazil of KPC-producing S. marcescens clinical isolate outside of a hospital environment. Caregivers should be alert for the presence of this isolate in the community setting. |
| Formato |
text/html |
| Identificador |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652015000400359 |
| Idioma(s) |
en |
| Publicador |
Instituto de Medicina Tropical |
| Fonte |
Revista do Instituto de Medicina Tropical de São Paulo v.57 n.4 2015 |
| Palavras-Chave | #Serratia marcescens #KPC-2 beta-lactamase #Carbapenemase #Multidrug-resistance |
| Tipo |
journal article |